Literature DB >> 2391551

McArdle's disease: two clinical expressions in the same pedigree.

A Papadimitriou1, P Manta, R Divari, A Karabetsos, E Papadimitriou, N Bresolin.   

Abstract

Two patients with McArdle's disease within the same pedigree and with two different clinical forms are presented. The first patient suffered from progressive muscle weakness and atrophy. Muscle morphology was that of myopathy. Residual activity of phosphorylase was 28% and sodium dodecyl sulphate electrophoresis showed decreased protein. The second case was typical of McArdle's disease, clinically and biochemically. It was concluded that the first patient was a heterozygote (residual activity 28% of normal) and the second was a homozygote, the genetic transmission being autosomal recessive.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2391551     DOI: 10.1007/bf00314633

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  9 in total

1.  Fatal infantile form of muscle phosphorylase deficiency.

Authors:  S DiMauro; P L Hartlage
Journal:  Neurology       Date:  1978-11       Impact factor: 9.910

2.  McArdle's disease--what limit to the age of onset?

Authors:  R H Hewlett; C Gardner-Thorpe
Journal:  S Afr Med J       Date:  1978-01-14

3.  Steroid myopathy complicating McArdle's disease.

Authors:  F L Mastaglia; J P McCollum; P F Larson; P Hudgson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-02       Impact factor: 10.154

4.  Debrancher deficiency: neuromuscular disorder in 5 adults.

Authors:  S DiMauro; G B Hartwig; A Hays; A B Eastwood; R Franco; M Olarte; M Chang; A D Roses; M Fetell; R S Schoenfeldt; L Z Stern
Journal:  Ann Neurol       Date:  1979-05       Impact factor: 10.422

5.  Congenital myopathy due to phosphorylase deficiency.

Authors:  F Cornelio; N Bresolin; S DiMauro; M Mora; M R Balestrini
Journal:  Neurology       Date:  1983-10       Impact factor: 9.910

6.  Late-onset Mcardle's disease with unusual electromyographic findings.

Authors:  R Pourmand; D B Sanders; H M Corwin
Journal:  Arch Neurol       Date:  1983-06

7.  McArdle's disease in two generations: autosomal recessive transmission with manifesting heterozygote.

Authors:  B Schmidt; S Servidei; A A Gabbai; A C Silva; A de Sousa Bulle de Oliveira; S DiMauro
Journal:  Neurology       Date:  1987-09       Impact factor: 9.910

8.  [McArdle's syndrome (myopathy in muscle phosphorylase deficiency)].

Authors:  K Schimrigk; H G Mertens; K Ricker; J Führ; P Eyer; D Pette
Journal:  Klin Wochenschr       Date:  1967-01-01

9.  Dominant inheritance of McArdle syndrome.

Authors:  L A Chui; T L Munsat
Journal:  Arch Neurol       Date:  1976-09
  9 in total
  1 in total

1.  Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.

Authors:  Judit Núñez-Manchón; Alfonsina Ballester-Lopez; Emma Koehorst; Ian Linares-Pardo; Daniëlle Coenen; Ignacio Ara; Carlos Rodriguez-Lopez; Alba Ramos-Fransi; Alicia Martínez-Piñeiro; Giuseppe Lucente; Miriam Almendrote; Jaume Coll-Cantí; Guillem Pintos-Morell; Alejandro Santos-Lozano; Joaquin Arenas; Miguel Angel Martín; Mauricio de Castro; Alejandro Lucia; Alfredo Santalla; Gisela Nogales-Gadea
Journal:  J Inherit Metab Dis       Date:  2018-06-20       Impact factor: 4.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.